The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVI. The Relationship of C-Peptide to the Incidence and Progression of Diabetic Retinopathy

The relationship between plasma C-peptide and the 6-year incidence and progression of diabetic retinopathy was examined in a population-based study in Wisconsin. Individuals with younger-onset (n = 548) and older-onset (n = 459) diabetes were included. C-peptide was measured by radioimmunoassay with Heeling's M1230 antiserum. Retinopathy was determined from stereoscopic fundus photographs. Younger- and older-onset insulinusing individuals with undetectable or low plasma Cpeptide (<0.3 nmol/L) at baseline had the highest incidence and rates of progression of retinopathy, whereas older-onset individuals with C-peptides >0.3 nmol/1 had the lowest incidence and rates of progression of retinopathy. However, within each group (youngeronset using insulin, older-onset using insulin, and olderonset not using insulin), after we controlled for other characteristics associated with retinopathy, there was no relationship between higher levels of C-peptide at baseline and lower 6-year incidence or progression of retinopathy. These data suggest that glycemic control, and not C-peptide, is related to the incidence and progression of diabetic retinopathy.

[1]  D L DeMets,et al.  Prevalence of diabetes mellitus in southern Wisconsin. , 1984, American journal of epidemiology.

[2]  K. M. West.  Epidemiology of diabetes and its vascular lesions , 1978 .

[3]  D L DeMets,et al.  Relation of ocular and systemic factors to survival in diabetes. , 1989, Archives of internal medicine.

[4]  D. DeMets,et al.  Wisconsin Epidemiologic Study of Diabetic Retinopathy: XII. Relationship of C-Peptide and Diabetic Retinopathy , 1990, Diabetes.

[5]  M. Mosier.  Circulating C-peptide and diabetic retinopathy. , 1984, Diabetes research.

[6]  R. Klein,et al.  Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. , 1994, Archives of internal medicine.

[7]  D L DeMets,et al.  Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. , 1988, JAMA.

[8]  R. Klein,et al.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. , 1994, Archives of ophthalmology.

[9]  Nathan Mantel,et al.  Chi-square tests with one degree of freedom , 1963 .

[10]  J. Ludvigsson,et al.  Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: Insulin antibodies and c‐peptide levels , 1990, Acta ophthalmologica.

[11]  L. Berglund,et al.  Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus. , 1991, The Journal of diabetic complications.

[12]  S. Madsbad,et al.  The Effect of Residual Beta‐cell Function on the Development of Diabetic Retinopathy , 1986, Diabetic medicine : a journal of the British Diabetic Association.

[13]  Langford Hg.  The hypertension detection and follow-up program. , 1984 .

[14]  H. Chase,et al.  Glucose control and the renal and retinal complications of insulin-dependent diabetes. , 1989, JAMA.

[15]  K. Watanabe,et al.  High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacity. , 1989, Diabetes research and clinical practice.

[16]  P. Watkins,et al.  C-peptide response to glucagon in diabetics with and without complications. , 1979, The New Zealand medical journal.

[17]  F L Ferris,et al.  Photocoagulation for diabetic macular edema. , 1987, Archives of ophthalmology.

[18]  T. Van Itallie.  Health implications of overweight and obesity in the United States. , 1985, Annals of internal medicine.

[19]  H. Kuzuya,et al.  Characterization of Seven C-peptide Antisera , 1978, Diabetes.

[20]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. , 1989, Archives of ophthalmology.

[21]  R. Klein,et al.  The incidence of vision loss in a diabetic population. , 1988, Ophthalmology.

[22]  R. W. Turkington,et al.  Insulin secretion in the diagnosis of adult-onset diabetes mellitus. , 1978, JAMA.

[23]  P. Wilson,et al.  Incidence of Diabetic Retinopathy and Relationship to Baseline Plasma Glucose and Blood Pressure , 1988, Diabetes Care.

[24]  P. Winocour,et al.  The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications. , 1990, Diabetes research and clinical practice.

[25]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.

[26]  L. Rand,et al.  Risk of Proliferative Diabetic Retinopathy in Juvenile-Onset Type I Diabetes: A 40-yr Follow-up Study , 1986, Diabetes Care.